{
  "data_version": "seed-0.6 · 2026-08-29",
  "source": "https://finance.foundation",
  "license": "CC BY 4.0",
  "entity": "company",
  "data": {
    "id": "abbvie",
    "name": "AbbVie",
    "legal_name": "AbbVie Inc.",
    "ticker": "ABBV",
    "exchange": "nyse",
    "country": "united-states",
    "sector": "Healthcare",
    "industry": "Pharmaceuticals",
    "market_cap_usd_bn": 390,
    "currency": "USD",
    "website": "https://www.abbvie.com",
    "founded": 2013,
    "description": "Large pharmaceutical company spun off from Abbott in 2013, with immunology blockbusters Skyrizi and Rinvoq succeeding Humira, plus the Allergan aesthetics portfolio (Botox).",
    "identifiers": {
      "lei": "FR5LCKFTG8054YNNRU85",
      "isin": "US00287Y1091",
      "figi": "BBG0025Y4RZ3"
    }
  },
  "links": {
    "html": "https://finance.foundation/companies/abbvie",
    "graph": "https://finance.foundation/api/v1/graph/companies/abbvie"
  }
}